{"id":3627348,"date":"2023-11-08T14:03:06","date_gmt":"2023-11-08T19:03:06","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/?post_type=scientist&p=3627348"},"modified":"2025-07-28T13:00:27","modified_gmt":"2025-07-28T17:00:27","slug":"michael-kress-ph-d","status":"publish","type":"scientist","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/","title":{"rendered":"Michael Kress, Ph.D."},"content":{"rendered":"
\n \n \n

\n \nDownload icon<\/title><\/svg>\n Download bio<\/a><\/p>\n \n

\n \nDownload icon<\/title><\/svg>\n Download photo<\/a><\/p>\n \n \n<\/div>\n\n\n
\n
\n

Michael Kress is senior vice president of development science and clinical supply at Merck Research Laboratories (MRL). In this role, Kress leads an interdisciplinary team responsible for drug substance, drug product, analytical and clinical supply of small molecules, biologics and vaccines for the company.<\/p>\n\n\n\n

Kress joined Merck in 1995 as senior research chemist within the process research group where his research focused on the development of efficient synthetic processes to a variety of drug development targets within Merck\u2019s diabetes and pain franchises. After joining Cephalon, Inc., Kress returned to Merck in 2007 as executive director of pharmaceutical development and was promoted to vice president of pharmaceutical research and development. During his tenure within drug product development, he supported key development programs and product launches in diabetes, sleep disorders and hepatitis C. Since 2021, Kress has led development sciences and clinical supply, bringing the drug substance, drug product, analytical and clinical supply functions together under one organization.<\/p>\n\n\n\n

Kress received his Bachelor of Science in chemistry from the Pennsylvania State University and his Ph.D. in synthetic chemistry from Harvard University. He is a member of the American Chemical Society, the American Association of Pharmaceutical Scientists and the Innovation and Quality Consortia. Kress was recently appointed to the Hilleman board of directors to help expand the access of lifesaving vaccines to patients through innovative science.<\/p>\n<\/div>\n\n\n\n

\n

<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

View more stories<\/h3>\t\t\t\t <\/div>\n\n
\n\t\t \n \n\t\t\t\t\t\t \n \n \n \n \n <\/picture>\n\t\t\t\t\t\t <\/span>\n
\n\t\t\t\t\t\t Innovation<\/small>\n
5 historical designations highlight groundbreaking scientific achievements<\/h5>

The American Chemical Society Landmark program recognizes important contributions to modern life through chemical sciences<\/p>\n <\/div>\n <\/a>\n\t\t\t \n \n\t\t\t\t\t\t \n \n \n \n \n <\/picture>\n\t\t\t\t\t\t <\/span>\n

\n\t\t\t\t\t\t Innovation<\/small>\n
Our Q3 2025 financial results<\/h5>

Merck\u2019s (NYSE: MRK) Q3 2025 sales performance reflects strength across oncology and animal health, as well as increasing contributions from new launches. Our company announced Q3 worldwide sales of $17.3 billion.\u200b\u200b \u201cIn the third quarter, we continued to execute on our strategy with important pipeline advancements, significant approvals and successful new product launches,\u201d said Rob […]<\/p>\n <\/div>\n <\/a>\n\t\t\t \n \n\t\t\t\t\t\t \n \n \n \n \n <\/picture>\n\t\t\t\t\t\t <\/span>\n

\n\t\t\t\t\t\t Innovation<\/small>\n
The new manufacturing facilities powering our US growth<\/h5>

It's been a groundbreaking year at new and augmented facilities focusing on biologics, vaccines, animal health and more<\/p>\n <\/div>\n <\/a>\n\t\t\t \n \n\t\t\t\t\t\t \n \n \n \n \n <\/picture>\n\t\t\t\t\t\t <\/span>\n

\n\t\t\t\t\t\t Innovation<\/small>\n
Understanding vision-threatening retinal conditions: Diabetic macular edema and wet AMD<\/h5>

Our scientists are researching new ways to address vision-threatening retinal conditions like diabetic macular edema and wet age-related macular degeneration (wet AMD)<\/p>\n <\/div>\n <\/a>\n\t\t\t \n \n\t\t\t\t\t\t \n \n \n \n \n <\/picture>\n\t\t\t\t\t\t <\/span>\n

\n\t\t\t\t\t\t Innovation<\/small>\n
Macrocyclic peptides: a new research frontier<\/h5>

Merck scientists are exploring macrocyclic peptides, a new way to combine the properties of a biologic in a pill<\/p>\n <\/div>\n <\/a>\n\t\t\t <\/div>\n\n

\n
\n\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t <\/div>\n\n
\n
\n\t\t\t\t\n\tPrevious<\/title>\n\t\n\t\n\t\n\t\n<\/svg>\n <\/div>\n
\n\t\t\t\t\n\tNext<\/title>\n\t\n\t\n\t\n\t\n<\/svg>\n <\/div>\n\n
\n \"Pause\"\/\n \"Play\"\/\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n","protected":false},"featured_media":3627571,"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"class_list":["post-3627348","scientist","type-scientist","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nMichael Kress, Ph.D. - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michael Kress, Ph.D. - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Michael Kress is senior vice president of development science and clinical supply at Merck Research Laboratories (MRL). In this role, Kress leads an interdisciplinary team responsible for drug substance, drug product, analytical and clinical supply of small molecules, biologics and vaccines for the company. Kress joined Merck in 1995 as senior research chemist within the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-28T17:00:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2023\/09\/Michael_Kress.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"666\" \/>\n\t<meta property=\"og:image:height\" content=\"664\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/\",\"url\":\"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/\",\"name\":\"Michael Kress, Ph.D. - Merck.com\",\"isPartOf\":{\"@id\":\"https:\/\/vip2-msd.com\/merckcom-migrated\/#website\"},\"datePublished\":\"2023-11-08T19:03:06+00:00\",\"dateModified\":\"2025-07-28T17:00:27+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vip2-msd.com\/merckcom-migrated\/#website\",\"url\":\"https:\/\/vip2-msd.com\/merckcom-migrated\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Michael Kress, Ph.D. - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/","og_locale":"en_US","og_type":"article","og_title":"Michael Kress, Ph.D. - Merck.com","og_description":"Michael Kress is senior vice president of development science and clinical supply at Merck Research Laboratories (MRL). In this role, Kress leads an interdisciplinary team responsible for drug substance, drug product, analytical and clinical supply of small molecules, biologics and vaccines for the company. Kress joined Merck in 1995 as senior research chemist within the […]","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/","og_site_name":"Merck.com","article_modified_time":"2025-07-28T17:00:27+00:00","og_image":[{"width":666,"height":664,"url":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2023\/09\/Michael_Kress.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/","name":"Michael Kress, Ph.D. - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"datePublished":"2023-11-08T19:03:06+00:00","dateModified":"2025-07-28T17:00:27+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/meet-our-scientists\/michael-kress-ph-d\/"]}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/scientist\/3627348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/scientist"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/scientist"}],"version-history":[{"count":44,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/scientist\/3627348\/revisions"}],"predecessor-version":[{"id":3671795,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/scientist\/3627348\/revisions\/3671795"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media\/3627571"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=3627348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}